PE11399A1 - Combinacion de loratadina y un descongestionante para el tratamiento del asma - Google Patents
Combinacion de loratadina y un descongestionante para el tratamiento del asmaInfo
- Publication number
- PE11399A1 PE11399A1 PE1997000968A PE00096897A PE11399A1 PE 11399 A1 PE11399 A1 PE 11399A1 PE 1997000968 A PE1997000968 A PE 1997000968A PE 00096897 A PE00096897 A PE 00096897A PE 11399 A1 PE11399 A1 PE 11399A1
- Authority
- PE
- Peru
- Prior art keywords
- patient
- asthma
- loratadine
- combination
- treatment
- Prior art date
Links
- 208000006673 asthma Diseases 0.000 title abstract 4
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 title abstract 2
- 229960003088 loratadine Drugs 0.000 title abstract 2
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 abstract 2
- 239000000739 antihistaminic agent Substances 0.000 abstract 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- 229940125715 antihistaminic agent Drugs 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 abstract 1
- 230000002249 decongestive effect Effects 0.000 abstract 1
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 abstract 1
- 229960002179 ephedrine Drugs 0.000 abstract 1
- 230000002650 habitual effect Effects 0.000 abstract 1
- 230000004199 lung function Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 229960001802 phenylephrine Drugs 0.000 abstract 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 abstract 1
- DLNKOYKMWOXYQA-APPZFPTMSA-N phenylpropanolamine Chemical group C[C@@H](N)[C@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-APPZFPTMSA-N 0.000 abstract 1
- 229960000395 phenylpropanolamine Drugs 0.000 abstract 1
- 206010039083 rhinitis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE AL USO COMBINADO DEL ANTIHISTAMINICO ANTISEDANTE LORATADINA Y DE UN DESCONGESTIONANTE PARA LA MANUFACTURA DE UN MEDICAMENTO PARA MEJORAR LA FUNCION PULMONAR DE UN PACIENTE QUE PADECE ASMA INCLUYENDO LA ADMINISTRACION AL PACIENTE DE UN TRATAMIENTO HABITUAL PARA LA RINITIS; EN DONDE DICHO DESCONGESTIVO SE SELECCIONA DE FENILPROPANOLAMINA, EFEDRINA, FENILEFRINA, PSEUDOEFEDRINA O UNA COMBINACION DE LAS MISMAS. SE MUESTRA QUE EL USO DE ANTIHISTAMINICOS QUE ERA CONTRAINDICADO SI EL PACIENTE TENIA ASMA, TENDRIA UN EFECTO BENEFICIOSO EN EL PACIENTE ASMATICO, INDEPENDIENTE SI EL PACIENTE PADECE O NO PADECE RINITIS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73966996A | 1996-10-31 | 1996-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE11399A1 true PE11399A1 (es) | 1999-02-09 |
Family
ID=24973307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1997000968A PE11399A1 (es) | 1996-10-31 | 1997-10-29 | Combinacion de loratadina y un descongestionante para el tratamiento del asma |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0941091A1 (es) |
| JP (1) | JP2000505104A (es) |
| KR (1) | KR20000052922A (es) |
| CN (1) | CN1235545A (es) |
| AR (1) | AR008908A1 (es) |
| AU (1) | AU731756B2 (es) |
| BR (1) | BR9712705A (es) |
| CA (1) | CA2268546A1 (es) |
| CO (1) | CO4910128A1 (es) |
| CZ (1) | CZ150999A3 (es) |
| HU (1) | HUP9904075A3 (es) |
| ID (1) | ID23431A (es) |
| IL (1) | IL129662A0 (es) |
| NO (1) | NO992062L (es) |
| NZ (1) | NZ335078A (es) |
| PE (1) | PE11399A1 (es) |
| PL (1) | PL333056A1 (es) |
| SK (1) | SK54599A3 (es) |
| TR (1) | TR199901003T2 (es) |
| WO (1) | WO1998018470A1 (es) |
| ZA (1) | ZA979731B (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1032392A4 (en) * | 1997-10-29 | 2001-05-09 | J Med Pharmaceuticals Inc | RHINITIS TREATMENT BY ANTIHISTAMINE / DECONGESTIVUM ADMINISTRATION |
| US6132758A (en) | 1998-06-01 | 2000-10-17 | Schering Corporation | Stabilized antihistamine syrup |
| IT1303671B1 (it) * | 1998-07-28 | 2001-02-23 | Nicox Sa | Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio |
| AU6018899A (en) * | 1998-09-10 | 2000-04-03 | Schering Corporation | Antihistamines for treating non-infective sinusitis or otitis media |
| US6521254B2 (en) | 1998-12-07 | 2003-02-18 | J-Med Pharmaceuticals, Inc. | Single-dose antihistamine/decongestant formulations for treating rhinitis |
| KR100505899B1 (ko) * | 1999-02-23 | 2005-08-01 | 주식회사유한양행 | 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물 |
| CN1161112C (zh) * | 1999-02-23 | 2004-08-11 | 株式会社柳韩洋行 | 含氯雷他定和伪麻黄碱的药物胶囊组合物 |
| WO2000057880A1 (en) * | 1999-03-29 | 2000-10-05 | Schering Corporation | Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine |
| AU2276801A (en) * | 1999-12-20 | 2001-07-03 | Schering Corporation | Extended release oral dosage composition |
| AU2277101A (en) * | 1999-12-20 | 2001-07-03 | Schering Corporation | Stable extended release oral dosage composition |
| WO2001078782A1 (en) * | 2000-04-14 | 2001-10-25 | J-Med Pharmaceuticals, Inc. | Single-dose antihistamine/decongestant formulations for treating rhinitis |
| WO2001089527A2 (en) * | 2000-05-24 | 2001-11-29 | Schering Corporation | Pharmaceutical composition comprising loratadine and a nasal decongestant |
| WO2003000264A1 (en) * | 2001-06-20 | 2003-01-03 | Schering Corporation | Antihistamines for the treatment of nasal congestion and nasal obstruction |
| CA2612179C (en) * | 2005-06-17 | 2016-08-02 | Aft Pharmaceuticals Limited | A pharmaceutical composition comprising loratadine and its use to treat patients with upper respiratory mucosal congestion |
| RU2423979C2 (ru) * | 2005-06-17 | 2011-07-20 | АФТ Фармасьютикалз Лимитед | Новая фармацевтическая композиция и ее применение в способе лечения пациентов с гиперемией и отеком слизистой оболочки верхних дыхательных путей |
| CA2653953C (en) * | 2006-06-01 | 2015-12-08 | Schering-Plough Healthcare Products, Inc. | Phenylephrine pharmaceutical formulations and compositions for colonic absorption |
| NZ573174A (en) * | 2006-06-01 | 2012-01-12 | Msd Consumer Care Inc | Sustained release pharmaceutical dosage form containing phenylephrine |
| KR101540191B1 (ko) * | 2014-02-24 | 2015-07-28 | 성균관대학교산학협력단 | 로라타딘을 포함하는 항염증용 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1110397A (en) * | 1964-10-02 | 1968-04-18 | Mead Johnson & Co | Ephedrine composition |
| US4990535A (en) * | 1989-05-03 | 1991-02-05 | Schering Corporation | Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine |
| US5407686A (en) * | 1991-11-27 | 1995-04-18 | Sidmak Laboratories, Inc. | Sustained release composition for oral administration of active ingredient |
| US5314697A (en) * | 1992-10-23 | 1994-05-24 | Schering Corporation | Stable extended release oral dosage composition comprising loratadine and pseudoephedrine |
| US5595997A (en) * | 1994-12-30 | 1997-01-21 | Sepracor Inc. | Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
-
1997
- 1997-10-29 BR BR9712705-1A patent/BR9712705A/pt not_active Application Discontinuation
- 1997-10-29 PL PL97333056A patent/PL333056A1/xx unknown
- 1997-10-29 AU AU49953/97A patent/AU731756B2/en not_active Ceased
- 1997-10-29 EP EP97912874A patent/EP0941091A1/en not_active Withdrawn
- 1997-10-29 ZA ZA9709731A patent/ZA979731B/xx unknown
- 1997-10-29 ID IDW990280D patent/ID23431A/id unknown
- 1997-10-29 TR TR1999/01003T patent/TR199901003T2/xx unknown
- 1997-10-29 WO PCT/US1997/019158 patent/WO1998018470A1/en not_active Ceased
- 1997-10-29 AR ARP970105033A patent/AR008908A1/es not_active Application Discontinuation
- 1997-10-29 CZ CZ991509A patent/CZ150999A3/cs unknown
- 1997-10-29 CA CA002268546A patent/CA2268546A1/en not_active Abandoned
- 1997-10-29 CO CO97063641A patent/CO4910128A1/es unknown
- 1997-10-29 KR KR1019990703790A patent/KR20000052922A/ko not_active Ceased
- 1997-10-29 NZ NZ335078A patent/NZ335078A/xx unknown
- 1997-10-29 CN CN97199404A patent/CN1235545A/zh active Pending
- 1997-10-29 JP JP10520579A patent/JP2000505104A/ja active Pending
- 1997-10-29 SK SK545-99A patent/SK54599A3/sk unknown
- 1997-10-29 IL IL12966297A patent/IL129662A0/xx unknown
- 1997-10-29 PE PE1997000968A patent/PE11399A1/es not_active Application Discontinuation
- 1997-10-29 HU HU9904075A patent/HUP9904075A3/hu unknown
-
1999
- 1999-04-29 NO NO992062A patent/NO992062L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20000052922A (ko) | 2000-08-25 |
| WO1998018470A1 (en) | 1998-05-07 |
| HUP9904075A3 (en) | 2002-02-28 |
| CA2268546A1 (en) | 1998-05-07 |
| EP0941091A1 (en) | 1999-09-15 |
| NZ335078A (en) | 2000-10-27 |
| CZ150999A3 (cs) | 1999-10-13 |
| AR008908A1 (es) | 2000-02-23 |
| SK54599A3 (en) | 2000-08-14 |
| BR9712705A (pt) | 1999-10-26 |
| NO992062D0 (no) | 1999-04-29 |
| AU731756B2 (en) | 2001-04-05 |
| NO992062L (no) | 1999-04-29 |
| CO4910128A1 (es) | 2000-04-24 |
| CN1235545A (zh) | 1999-11-17 |
| ZA979731B (en) | 1998-04-29 |
| HUP9904075A2 (hu) | 2000-05-28 |
| JP2000505104A (ja) | 2000-04-25 |
| ID23431A (id) | 2000-04-20 |
| IL129662A0 (en) | 2000-02-29 |
| PL333056A1 (en) | 1999-11-08 |
| AU4995397A (en) | 1998-05-22 |
| TR199901003T2 (xx) | 1999-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69721766D1 (de) | Neue arzneiformulierung | |
| DE69400435D1 (de) | Verwendung von carbamazepine und oxcarbazepine zur behandlung von parkinson und den parkinson-syndromen | |
| YU59092A (sh) | Formulacije aerosola koji ne sadrže hlorofluorougljenična jedinjenja | |
| BRPI0108435B8 (pt) | formulação e uso de entecavir de baixa dose | |
| BR0008276A (pt) | Combinações de formoterol e propionato de fluticasona para asma | |
| NO20042596L (no) | Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1 | |
| ATE329608T1 (de) | Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung | |
| AR016798A1 (es) | Uso de una cepa de lactobacillus para la elaboracion de un medicamento | |
| ES2166111T3 (es) | Uso de tiagabina para el tratamiento de trastornos del sueño. | |
| NO990522L (no) | Anvendelse av <beta>-ark mimetika som protease- og kinaseinhibatorer av transkripsjonsfaktorer | |
| AR008908A1 (es) | Uso de loratadina y un descongestivo para preparar un medicamento para mejorar la funcion pulmonar de un paciente que padece asma | |
| NO20004419D0 (no) | Ny anvendelse | |
| ATE291914T1 (de) | Zolmitriptanhaltige arzneizusammensetzungen | |
| DE60002885D1 (de) | Wässrige formulierung zur nasalen verabreichung | |
| DE60214527D1 (de) | Verwendung von flumazenil bei der entwicklung eines arzneimittels zur behandlung von alkoholabhängigkeit | |
| AR023687A1 (es) | Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa | |
| EE9700366A (et) | Angiotensiini II tüüp 1 retseptori antagonistide kasutamine düspeptiliste sümptomite profülaktikas ja/või ravis kasutatava ravimi valmistamiseks ja angiotensiini II tüüp 1 retseptori antagoniste sisaldavad ravimpreparaadid | |
| NO20013414L (no) | Ny anvendelse av melagatran | |
| ATE271852T1 (de) | Verbesserte inhalationspräparate | |
| TR199901385T2 (xx) | Piperidin t�revleri. | |
| NO20032006D0 (no) | Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser | |
| BG105984A (bg) | Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението | |
| HUP9701606A2 (hu) | Szulbutiamin alkalmazása bizonyos pszichomotoros és pszichointellektuális rendellenességek kezelésére használható gyógyszerkészítmények előállítására | |
| BR0206918A (pt) | Uso de iloperidona | |
| ATE291904T1 (de) | 2,4-dichlorbenzylalkohol und amylmetakresol gegen hiv-infektion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |